Want to join the conversation?
$JNJ'S Janssen-Cilag International said Committee for Medicinal Products for Human Use (CHMP) of European Medicines Agency (EMA) has adopted Positive Opinion, recommending broadening existing marketing authorisation for ibrutinib as single agent for treatment of adult patients with previously untreated chronic lymphocytic leukaemia (CLL).
The latest earnings report by $VZ shows how it is losing customers despite offering the unlimited data plans, a record for the company.
$BEBE is closing down all its stores by the end of May.
$WFC agreed to hike its payout in a class-action settlement over unauthorized accounts by $32 million to $142 million for its retail sales practices. The settlement will now include customers who were impacted as early as May 2002.